Ratings by Barclays (James Gordon)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/6/2026 | GlaxoSmithKline | GSK | Downgrade | Underweight (Equalweight) |
49.02 (54.51) |
11.2% | Details |
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/6/2026 | GlaxoSmithKline | GSK | Downgrade | Underweight (Equalweight) |
49.02 (54.51) |
11.2% | Details |